Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in biocon

Sebi Bars Allegro Capital, Individual For Insider Trading Activities In Biocon Shares

Allegro Capital and its director as well as major shareholder Kunal Ashok Kashyap have been fined Rs 10 lakh each, according to an order by Sebi dated July 8.

Read More

Insider Trading Case: Sebi Bars Biocon's Official From Securities Mkt For 3 Months, Levies Fine

Biocon had announced information relating to its collaboration with Sandoz and the period of unpublished price sensitive information (UPSI) was from December 20, 2017 to January 18, 2018

Read More

Sebi Fines Biocon, Its Designated Person For Violating Mkt Norms

Market norms require that violation of code of conduct (CoC) be informed to the regulator 'promptly.' Biocon informed Sebi after 28 days of becoming aware of violation of company's code of conduct.

Read More

Biocon Case: Sebi Bans 6 Entities For 2 Yrs For Manipulative Trades

The regulator has directed these four entities to disgorge the unlawful gains made by them along with an interest of 12 per cent per annum.

Read More

Biocon Q4 Net Profit Surges 86 % To Rs 296.4 Cr

Total income of the company rose by 26.13 per cent to Rs 2,044.1 crore as against Rs 1,620.6 crore for the same period year ago, the company said in a regulatory filing.

Read More

Biocon's Arm Gets GMP Compliance Certificate From UK's Health Regulator MHRA For Bengaluru Facility

The certificate, which includes manufacturing and packaging of tablets and capsules in the non-potent and potent blocks of the facility, was issued based on a remote inspection in the week of March 22, 2021

Read More

Biocon Biologics Elevates Shreehas Tambe As Deputy Chief Executive Officer

Prior to being appointed as deputy chief executive officer, Tambe was the chief operating officer and a key member of the executive leadership team at the company.

Read More

Biocon Biologics To Partner With International Diabetes Federation

Global Head of Market Access & Policy, Biocon Biologics, Alexander Zach, said:'Given our extensive experience in providing affordable insulins globally, we believe we can contribute and support IDF in driving real policy and access actions that will transform lives and diabetes care.

Read More

Biocon Q3 Net Profit Falls 19 % To Rs 186.6 Cr

Expenses rose to Rs 1,642.6 crore for the December quarter, an increase of 14.52 per cent, as against Rs 1,434.3 crore in the year-ago period.

Read More

Syngene reports 11 pc growth in Q3 PAT at Rs 102 cr

Syngene reports 11 pc growth in Q3 PAT at Rs 102 cr

Read More

Syngene International Takes Up Covid-19 Testing In Bangalore

The company opens COVID-19 RT-PCR testing centre to support Bengaluru hospitals

Read More

Biocon Rises 5% After Launch Of Ogivri In US Market

Biotechnology major Biocon and drug firm Mylan NV on Monday announced the launch of biosimilar Ogivri, used for treatment of certain breast and gastric cancers, in the US market.

Read More

Biocon Elevates Siddharth Mittal To CEO, Joint MD's Position

Mittal takes over from Arun Chandavarkar who retired on November 30 after 29 years of contribution to the company's evolution.

Read More